Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q1 2024 vs. Q4 2023
How the institutions holding Alterity Therapeutics Ltd changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 9 | 1 | 10 | +2 |
| Shares | 87.0K | 5 | 94.0K | +6.93K (+8.0%) |
| Value | $226.7K | $12 | $193.8K | −$32.9K (−14.5%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Alterity Therapeutics Ltd at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 18,279 | $37.5K | 0.00% |
| XTX Topco Ltd | 17,425 | $35.7K | 0.00% |
| CoreCap Advisors, LLC | 21 | $43 | 0.00% |
| UBS Group AG | 2 | $4 | 0.00% |
Sold out (2)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Bank of Montreal | 14,907 | $47.0K |
| Virtu Financial LLC | 10,799 | $27.0K |
Not filed for Q1 2024 yet (1)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Coppell Advisory Solutions LLC | 5 | $12 |